Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Other Operating Expenses (2017 - 2025)

Historic Other Operating Expenses for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 11 years, with Q2 2025 value amounting to -$1.1 million.

  • Lifecore Biomedical, Inc. \De\'s Other Operating Expenses rose 5454.17% to -$1.1 million in Q2 2025 from the same period last year, while for May 2025 it was $409000.0, marking a year-over-year decrease of 9896.46%. This contributed to the annual value of $409000.0 for FY2025, which is 9896.46% down from last year.
  • As of Q2 2025, Lifecore Biomedical, Inc. \De\'s Other Operating Expenses stood at -$1.1 million, which was up 5454.17% from -$600000.0 recorded in Q1 2025.
  • In the past 5 years, Lifecore Biomedical, Inc. \De\'s Other Operating Expenses ranged from a high of $21.0 million in Q1 2024 and a low of -$2.4 million during Q2 2024
  • For the 4-year period, Lifecore Biomedical, Inc. \De\'s Other Operating Expenses averaged around $4.7 million, with its median value being $900000.0 (2024).
  • As far as peak fluctuations go, Lifecore Biomedical, Inc. \De\'s Other Operating Expenses soared by 35000.0% in 2024, and later tumbled by 10285.71% in 2025.
  • Over the past 4 years, Lifecore Biomedical, Inc. \De\'s Other Operating Expenses (Quarter) stood at $2.1 million in 2022, then surged by 881.97% to $20.7 million in 2023, then crashed by 94.2% to $1.2 million in 2024, then crashed by 190.92% to -$1.1 million in 2025.
  • Its Other Operating Expenses was -$1.1 million in Q2 2025, compared to -$600000.0 in Q1 2025 and $1.2 million in Q4 2024.